Peer Review History

Original SubmissionNovember 14, 2025
Decision Letter - Saima Aleem, Editor

-->PONE-D-25-61426-->-->Experiences shaping research career intention among Black, Hispanic, and Indigenous first-year medical students in the United States: a qualitative study-->-->PLOS One

Dear Dr. Venkataraman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 10 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Saima Aleem

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. Thank you for stating the following financial disclosure:

“This study was funded by the National Institute of Health (NIH), project number R35GM153263. The NIH did not have any role in the study outside of funding. The authors listed are all independent from the NIH and had full access to all the data in the study and can take full responsibility for the integrity of the data and the accuracy of the data analysis.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: N/A

Reviewer #2: N/A

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: No

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: This manuscript addresses an important and timely topic in medical education by exploring early experiences shaping research career intentions among students underrepresented in medicine. The qualitative design is appropriate, and the study is methodologically sound, with clear descriptions of sampling, data collection, and analytic processes. The findings are well supported by rich participant quotations, and the themes are coherent, analytically grounded, and meaningfully interpreted in relation to existing literature.

The manuscript is clearly written and well structured, and the conclusions are appropriately aligned with the data presented, without overstatement. The discussion thoughtfully situates the findings within broader debates on mentorship, equity, and the physician-scientist pipeline, offering relevant and actionable implications for educators and institutions.

One area that would benefit from further attention is data availability. While supplementary materials are provided, access to the full de-identified dataset is restricted and contingent upon request and completion of the parent longitudinal study. Greater alignment with PLOS ONE’s data-sharing policy, or a clearer justification for the stated restrictions, would strengthen transparency.

Overall, this is a strong and valuable contribution to the literature. With minor clarifications regarding data availability, the manuscript would be suitable for publication.

Reviewer #2: This manuscript presents a rigorous, thoughtfully conducted qualitative study examining early experiences shaping research career intentions among first-year students underrepresented in medicine. The study is clearly written, methodologically transparent, and robust empirical work with an appropriate analytical approach. The data are rich, and the themes are well supported by participant quotes. Overall, this is a strong paper that could benefit from minor revisions to further sharpen conceptual clarity and alignment between framing and findings.

First, the manuscript draws on several relevant concepts, including social cognitive career theory, identity concordance, minority tax, social capital, and values alignment. While all are appropriate, the Discussion occasionally assigns these concepts a stronger explanatory role than warranted by a qualitative descriptive design (mainly through words such as drives, determines, shapes etc.). I would recommend clarifying that these frameworks function as interpretive lenses rather than analytic or causal models, and slightly nuancing language that implies determination or directionality.

Second, the study's contribution and novelty could be made more explicit, for example, by briefly and clearly stating what this study adds beyond existing work, particularly the focus on the first year of medical school which is rarely examined, the early emergence of value misalignment with academic research culture, and the way residency competitiveness is already shaping research engagement at this stage of training.

Finally, the participant and public involvement section is a strength, but could be slightly streamlined to maintain a descriptive rather than evaluative tone. At the moment, it sounds more like advocacy, whereas the normative statements in this section would fit better in the Discussion.

These are relatively minor issues that do not detract from the overall quality of the work. With these revisions, the manuscript would make a valuable and methodologically sound contribution to the literature on medical education and research career development.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

Reviewer #2: Yes:Sofiya Abedali

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

Attachments
Attachment
Submitted filename: Reviewer Report.docx
Revision 1

JOURNAL REQUIREMENTS

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: We have edited the manuscript to ensure that it meets the PLOS ONE style requirements, including for file naming.

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

Response: We have now included a completed version of the PLOS ONE questionnaire on inclusivity in global research as Supporting Information and referenced it in the manuscript text, as requested.

Modified text (lines 212-214): “Additional information regarding the ethical, cultural, and scientific considerations specific to inclusivity in global research is included in the Supporting Information (S3 Checklist).”

3. Thank you for stating the following financial disclosure: “This study was funded by the National Institute of Health (NIH), project number R35GM153263. The NIH did not have any role in the study outside of funding. The authors listed are all independent from the NIH and had full access to all the data in the study and can take full responsibility for the integrity of the data and the accuracy of the data analysis.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

Response: The funders had no role in the study. We have now included the suggested statement verbatim in our cover letter.

4. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third-party organization, and please include the full citation of where the data can be found.

Response: We have amended our data statement to comply with both the PLOS ONE Data Policy and the terms of the verbal informed consent obtained from study participants.

Modified text (‘Data Availability’ statement): “Due to the highly sensitive nature of the data collected in this study, the data cannot be made publicly available in order to protect participant confidentiality and to comply with the terms of the verbal informed consent obtained from participants. At the time of consent, participants were informed that access to their information would be restricted to the research team and individuals responsible for research oversight, and that the data would not be shared with any parties outside the investigative team, including program leadership at their respective institutions. Questions regarding data access or participant protections may be directed to the Yale University Human Research Protection Program (HRPP@yale.edu).”

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

Response: We have included a full ethics statement with the full name of the IRB who approved our study and explained our informed verbal consent process in the ‘Methods’ section, as requested.

Associated text (lines 137-144): “Recruitment ended on May 9, 2024. Interested participants were sent the consent form (detailing the study aims, voluntary nature of participation, confidentiality protocols etc.) for review in advance of their interview. During the interview, the interviewer read and reviewed the consent language with the participant, asked if there were questions or answered questions and asked if they agreed to proceed with the interview. Participants were informed that they could choose not to participate (with no professional or other consequences) and choose to end the interview at any time. We documented that date informed verbal consent was obtained in REDCap. The Yale University Institutional Review Board approved all study procedures.”

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response: We have now included captions for the Supporting Information files at the end of the manuscript (see lines 841-844) and updated in-text citations (see lines 150, 180, 213-214, 216, 217) to match accordingly.

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Response: The reviewers and editor did not make such recommendations.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: We have reviewed the reference list for completeness and accuracy. To our knowledge, we have not cited any retracted articles. However, we found a duplicated reference (# 14 and # 45 in the previous version) and have remediated the duplication in the revision.

REVIEWER’S COMMENTS

Reviewer #1:

1. One area that would benefit from further attention is data availability. While supplementary materials are provided, access to the full de-identified dataset is restricted and contingent upon request and completion of the parent longitudinal study. Greater alignment with PLOS ONE’s data-sharing policy, or a clearer justification for the stated restrictions, would strengthen transparency.

Response: We appreciate this important point. We have now amended the Data Sharing statement to reflect greater adherence with PLOS ONE’s data sharing policy and the terms of the verbal informed consent obtained from study participants.

Modified text (‘Data Availability’ statement): “Due to the highly sensitive nature of the data collected in this study, the data cannot be made publicly available in order to protect participant confidentiality and to comply with the terms of the verbal informed consent obtained from participants. At the time of consent, participants were informed that access to their information would be restricted to the research team and individuals responsible for research oversight, and that the data would not be shared with any parties outside the investigative team, including program leadership at their respective institutions. Questions regarding data access or participant protections may be directed to the Yale University Human Research Protection Program (HRPP@yale.edu).”

Reviewer #2:

1. First, the manuscript draws on several relevant concepts, including social cognitive career theory, identity concordance, minority tax, social capital, and values alignment. While all are appropriate, the Discussion occasionally assigns these concepts a stronger explanatory role than warranted by a qualitative descriptive design (mainly through words such as drives, determines, shapes etc.). I would recommend clarifying that these frameworks function as interpretive lenses rather than analytic or causal models, and slightly nuancing language that implies determination or directionality.

Response: We thank the reviewer for this insightful and constructive feedback. As suggested, we have nuanced and softened the causal-sounding language in the ‘Discussion’ as well as throughout the manuscript. We have also added a line in the ‘Limitations’ to explicitly clarify the epistemic limits of the work and findings.

Modified text (lines 522-524): “Our findings highlight four interconnected domains of experience that participants described as salient in how they made sense of early research engagement and research career possibilities…”

Modified text (lines 546-549): “Participants described structured research opportunities as especially important in supporting their confidence and navigation of research spaces, particularly for students who perceived themselves as lacking prior exposure or professional networks.”

Modified text (lines 571-574): “Identity-concordant mentorship was described by participants as particularly meaningful in fostering a sense of belonging and possibility within research spaces, aligning with literature showing that representation supports persistence in STEM and academic careers.[28,36]”

Modified text (lines 604; paragraph title): “A sense of value misalignment and research disengagement”

Modified text (lines 605-608): “While our findings span distinct experiential domains, a consistent thread was participants’ references to perceived value incongruence when reflecting on their early research experiences, which influenced how they articulated enthusiasm, ambivalence, or hesitation towards future research engagement.”

Modified text (lines 631-634): “Fourth, consistent with a qualitative descriptive approach, the concepts referenced such as social cognitive career theory, identity concordance, minority tax, social capital, and values alignment, are used to interpret participants’ accounts rather than to imply causal relationships or predict research career trajectories.”

Modified text (lines 674-676): “This qualitative study offers an in-depth examination of experiences first-year URiM medical students described as informing their engagement with research and how they weighed the possibility of physician scientist careers.”

Modified text (lines 678-679): “…and structural barriers intensified by residency-driven publication pressures influenced how they engaged with research and evaluated research careers.”

2. Second, the study's contribution and novelty could be made more explicit, for example, by briefly and clearly stating what this study adds beyond existing work, particularly the focus on the first year of medical school which is rarely examined, the early emergence of value misalignment with academic research culture, and the way residency competitiveness is already shaping research engagement at this stage of training.

Response: We appreciate this thoughtful comment and have added statements in the ‘Discussion’ and ‘Conclusion’ to explicitly highlight the more novel findings of this study.

Modified text (lines 529-538): “These findings extend the literature by capturing how these experiences unfold at a formative period seldom examined in depth, particularly via qualitative enquiry. While prior work has examined URiM-specific barriers to academic medicine careers more broadly,[11,24] few studies have focused on the early medical school period or investigated how RCI specifically begins to emerge and evolve…Notably, even at this early stage of their training, participants reflected on their research experiences using interpretive lenses of values alignment, structural inequity, and residency competitiveness.”

Modified text (lines 585-587): “Our findings suggest that pressures associated with these benchmarks (which our study participants were acutely aware of) are already influencing how students approach and evaluate research as early as the first year of medical school.”

Modified text (lines 614-616): “Notably, students described these value tensions as emerging during the first year of medical school, highlighting that questions about alignment with academic research culture can arise early in medical training.”

Modified text (lines 679-682): “Notably, even at this early stage of medical training, students described tensions between their personal values and prevailing academic research culture, framing research less as a meaningful pursuit and more as a strategic obligation.”

3. Finally, the participant and public involvement section is a strength, but could be slightly streamlined to maintain a descriptive rather than evaluative tone. At the moment, it sounds more like advocacy, whereas the normative statements in this section would fit better in the Discussion.

Response: We thank the reviewer for this helpful observation. In response, we revised the Participant and Public Involvement section to maintain a more neutral, descriptive tone focused on clearly documenting how URiM students were involved across stages of the study (e.g., refinement of research questions, recruitment, data collection, analysis, and manuscript preparation). We removed or avoided evaluative and normative language and limited this section to factual reporting of participant involvement. We believe these revisions better align the section with conventions for reporting participant and public involvement.

Modified text (lines 202-210): “URiM medical students were involved at multiple stages of this study. The project was conceived by academic medicine faculty engaged in mentoring URiM medical students and informed by their observations of student engagement in research. URiM students contributed to the refinement of research questions and served as the primary study participants. URiM students also participated in recruitment, conducted interviews, contributed to coding and analysis, and collaborated in authoring and revising the manuscript. The interview guide was piloted with a small group of URiM students to assess clarity and burden. All participants were financially compensated and invited to share feedback at the conclusion of their interviews, though they did not provide feedback on the study findings.”

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Saima Aleem, Editor

Experiences shaping research career intention among Black, Hispanic, and Indigenous first-year medical students in the United States: a qualitative study

PONE-D-25-61426R1

Dear Dr. Venkataraman,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Saima Aleem

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Saima Aleem, Editor

PONE-D-25-61426R1

PLOS One

Dear Dr. Venkataraman,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Saima Aleem

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .